Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Modelling interaction between HIV-1 Nef and calnexin.

Adzhubei AA, Anashkina AA, Tkachev YV, Kravatsky YV, Pushkarsky T, Kulkarni A, Makarov AA, Bukrinsky MI.

AIDS. 2018 Sep 24;32(15):2103-2111. doi: 10.1097/QAD.0000000000001951.

PMID:
30005006
2.

Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection.

Kirichenko TV, Myasoedova VA, Shimonova TE, Melnichenko AA, Sviridov D, Sobenin IA, Mazus AI, Orekhov AN, Bukrinsky MI.

Biosci Rep. 2018 Jul 18;38(4). pii: BSR20180597. doi: 10.1042/BSR20180597. Print 2018 Aug 31.

3.

Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.

Kuniholm MH, Liang H, Anastos K, Gustafson D, Kassaye S, Nowicki M, Sha BE, Pawlowski EJ, Gange SJ, Aouizerat BE, Pushkarsky T, Bukrinsky MI, Prasad VR.

AIDS. 2017 Nov 28;31(18):2483-2492. doi: 10.1097/QAD.0000000000001648.

4.

HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni.

Suttiprapa S, Rinaldi G, Tsai IJ, Mann VH, Dubrovsky L, Yan HB, Holroyd N, Huckvale T, Durrant C, Protasio AV, Pushkarsky T, Iordanskiy S, Berriman M, Bukrinsky MI, Brindley PJ.

PLoS Pathog. 2016 Oct 20;12(10):e1005931. doi: 10.1371/journal.ppat.1005931. eCollection 2016 Oct.

5.

New clues to understanding HIV nonprogressors: low cholesterol blocks HIV trans infection.

Prasad VR, Bukrinsky MI.

MBio. 2014 Jun 10;5(3):e01396-14. doi: 10.1128/mBio.01396-14.

6.

HIV-1 accessory proteins: VpR.

Zhao RY, Bukrinsky MI.

Methods Mol Biol. 2014;1087:125-34. doi: 10.1007/978-1-62703-670-2_11.

7.

Cyclophilin A cooperates with MIP-2 to augment neutrophil migration.

Heine SJ, Olive D, Gao JL, Murphy PM, Bukrinsky MI, Constant SL.

J Inflamm Res. 2011;4:93-104. doi: 10.2147/JIR.S20733. Epub 2011 Jun 3.

8.

Blocking cyclophilins in the chronic phase of asthma reduces the persistence of leukocytes and disease reactivation.

Stemmy EJ, Balsley MA, Jurjus RA, Damsker JM, Bukrinsky MI, Constant SL.

Am J Respir Cell Mol Biol. 2011 Nov;45(5):991-8. doi: 10.1165/rcmb.2011-0007OC. Epub 2011 Apr 14.

9.

Vpr-host interactions during HIV-1 viral life cycle.

Zhao RY, Li G, Bukrinsky MI.

J Neuroimmune Pharmacol. 2011 Jun;6(2):216-29. doi: 10.1007/s11481-011-9261-z. Epub 2011 Feb 12. Review.

10.

A cell-impermeable cyclosporine A derivative reduces pathology in a mouse model of allergic lung inflammation.

Balsley MA, Malesevic M, Stemmy EJ, Gigley J, Jurjus RA, Herzog D, Bukrinsky MI, Fischer G, Constant SL.

J Immunol. 2010 Dec 15;185(12):7663-70. doi: 10.4049/jimmunol.1001707. Epub 2010 Nov 5.

11.

Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus.

Weinstein RS, Weinstein MM, Alibek K, Bukrinsky MI, Brichacek B.

BMC Immunol. 2010 May 18;11:23. doi: 10.1186/1471-2172-11-23.

12.

A cyclosporin derivative discriminates between extracellular and intracellular cyclophilins.

Malesević M, Kühling J, Erdmann F, Balsley MA, Bukrinsky MI, Constant SL, Fischer G.

Angew Chem Int Ed Engl. 2010;49(1):213-5. doi: 10.1002/anie.200904529. No abstract available.

13.

Analysis of viral and cellular proteins in HIV-1 reverse transcription complexes by co-immunoprecipitation.

Iordanskiy SN, Bukrinsky MI.

Methods Mol Biol. 2009;485:121-34. doi: 10.1007/978-1-59745-170-3_9.

14.

Targeting the chemotactic function of CD147 reduces collagen-induced arthritis.

Damsker JM, Okwumabua I, Pushkarsky T, Arora K, Bukrinsky MI, Constant SL.

Immunology. 2009 Jan;126(1):55-62. doi: 10.1111/j.1365-2567.2008.02877.x. Epub 2008 Jun 14.

15.

Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A.

Damsker JM, Bukrinsky MI, Constant SL.

J Leukoc Biol. 2007 Sep;82(3):613-8. Epub 2007 May 31.

16.

Novel approach to inhibit asthma-mediated lung inflammation using anti-CD147 intervention.

Gwinn WM, Damsker JM, Falahati R, Okwumabua I, Kelly-Welch A, Keegan AD, Vanpouille C, Lee JJ, Dent LA, Leitenberg D, Bukrinsky MI, Constant SL.

J Immunol. 2006 Oct 1;177(7):4870-9.

17.

Extracellular cyclophilins contribute to the regulation of inflammatory responses.

Arora K, Gwinn WM, Bower MA, Watson A, Okwumabua I, MacDonald HR, Bukrinsky MI, Constant SL.

J Immunol. 2005 Jul 1;175(1):517-22.

18.

Cell surface expression of CD147/EMMPRIN is regulated by cyclophilin 60.

Pushkarsky T, Yurchenko V, Vanpouille C, Brichacek B, Vaisman I, Hatakeyama S, Nakayama KI, Sherry B, Bukrinsky MI.

J Biol Chem. 2005 Jul 29;280(30):27866-71. Epub 2005 Jun 9.

19.

Cyclophilins: unexpected messengers in intercellular communications.

Bukrinsky MI.

Trends Immunol. 2002 Jul;23(7):323-5. Review. No abstract available.

PMID:
12103338
20.

HIV-1 nuclear import: in search of a leader.

Bukrinsky MI, Haffar OK.

Front Biosci. 1999 Oct 15;4:D772-81.

PMID:
10525473
21.

CNI-H0294, a nuclear importation inhibitor of the human immunodeficiency virus type 1 genome, abrogates virus replication in infected activated peripheral blood mononuclear cells.

Haffar OK, Smithgall MD, Popov S, Ulrich P, Bruce AG, Nadler SG, Cerami A, Bukrinsky MI.

Antimicrob Agents Chemother. 1998 May;42(5):1133-8.

22.

HIV-1 nuclear import: matrix protein is back on center stage, this time together with Vpr.

Bukrinsky MI, Haffar OK.

Mol Med. 1998 Mar;4(3):138-43. Review. No abstract available.

23.

HIV-1 nuclear import: in search of a leader.

Bukrinsky MI, Haffar OK.

Front Biosci. 1997 Dec 1;2:d578-87. Review.

PMID:
9366553
24.

Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism.

Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK.

Glia. 1996 Mar;16(3):276-84.

PMID:
8833198
25.

Anti-idiotypic antibody to the V3 domain of gp120 binds to vimentin: a possible role of intermediate filaments in the early steps of HIV-1 infection cycle.

Thomas EK, Connelly RJ, Pennathur S, Dubrovsky L, Haffar OK, Bukrinsky MI.

Viral Immunol. 1996;9(2):73-87.

PMID:
8822624
26.

Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.

Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE.

J Exp Med. 1995 Feb 1;181(2):735-45.

27.

The neuropathogenesis of HIV-1 infection.

Gendelman HE, Lipton SA, Tardieu M, Bukrinsky MI, Nottet HS.

J Leukoc Biol. 1994 Sep;56(3):389-98. Review.

PMID:
8083614
28.

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

Heinzinger NK, Bukrinsky MI, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M.

Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7311-5.

29.

Reduced nuclear import of human immunodeficiency virus type 1 preintegration complexes in the presence of a prototypic nuclear targeting signal.

Gulizia J, Dempsey MP, Sharova N, Bukrinsky MI, Spitz L, Goldfarb D, Stevenson M.

J Virol. 1994 Mar;68(3):2021-5.

30.

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Bukrinsky MI, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M.

Nature. 1993 Oct 14;365(6447):666-9.

PMID:
8105392
31.

Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.

Bukrinsky MI, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9.

32.

Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.

Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M.

Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6580-4.

33.

Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.

Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M.

Science. 1991 Oct 18;254(5030):423-7.

PMID:
1925601
34.

Posttranslational modifications within the HIV-1 envelope glycoprotein which restrict virus assembly and CD4-dependent infection.

Haggerty S, Dempsey MP, Bukrinsky MI, Guo L, Stevenson M.

AIDS Res Hum Retroviruses. 1991 Jun;7(6):501-10.

PMID:
1931229
35.

Highly immunogenic human immunodeficiency viruslike particles are produced by recombinant vaccinia virus-infected cells.

Vzorov AN, Bukrinsky MI, Grigoriev VB, Tentsov YYu, Bukrinskaya AG.

AIDS Res Hum Retroviruses. 1991 Jan;7(1):29-36.

PMID:
1901721
36.
37.

Plus strand of the HIV provirus DNA is expressed at early stages of infection.

Bukrinsky MI, Etkin AF.

AIDS Res Hum Retroviruses. 1990 Apr;6(4):425-6. No abstract available. Erratum in: AIDS Res Hum Retroviruses 1990 Jun;6(6):825.

PMID:
2340203
38.
39.

False-positive sera do not react with human immunodeficiency virus (HIV) gag-encoded recombinant antigen.

Bukrinsky MI, Syrtsev VA, Popov SA, Barsov EV, Chaplinskas SA, Karamov EV.

J Med Virol. 1989 Jan;27(1):72-5.

PMID:
2466101
41.

Reactivity to gag- and env-related proteins in immunoblot assay is not necessarily indicative of HIV infection.

Bukrinsky MI, Chaplinskas SA, Syrtsev VA, Bravkilene LA, Philippov YV.

AIDS. 1988 Oct;2(5):405-6. No abstract available.

PMID:
3146277
42.

Supplemental Content

Loading ...
Support Center